Stock Movers

On this episode of stock movers: Nike (NKE) shares rose on Wednesday after CEO Elliott Hill reported the purchase of about $1 million in shares. Corcept (CORT) shares fell after US regulators rejected the company’s drug to treat a form of high blood pressure. The Food and Drug Administration “could not arrive at a favorable benefit-risk assessment” for the company’s drug, relacorilant, without more evidence of its effectiveness, the Redwood City, California-based company said in a statement Wednesday. Trump Media and Technology Group (DJT) shares rose on news the company, which operates President Donald Trump’s Truth Social platform, plans to issue a new cryptocurrency, which will be distributed among its shareholders. See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:- Vanda Pharmaceuticals (VNDA) shares soar as much as 24% in premarket trading on Wednesday after the biopharmaceutical company said the US FDA has approved Nereus (tradipitant) for the prevention of vomiting induced by motion.- Nike (NKE) shares rose 1.6% in postmarket trading after CEO Elliott Hill reported the purchase of about $1 million in shares.- The S&P 500 Index is poised to end 2025 up more than 17% as the bull market continues for a third year driven by enthusiasm for artificial intelligence. The AI trade broadened out this year, as chip stocks again led the S&P 500 but were joined by the shares of companies tied to building the data centers that will power the technology. Three of the index’s top 10 performers in 2025 were data storage companies, which are among the main beneficiaries of the hundreds of billions of dollars in pledged spending by the giant AI cloud service providers known as hyperscalers. On the flip side, economic uncertainty from President Donald Trump’s sweeping tariffs weighed on the shares of consumer companies, while health-care stocks struggled with uncertainty surrounding the administration’s policies and pressure on drug prices. See omnystudio.com/listener for privacy information.

On this episode of Stock Movers: - Meta (META) closed 1.1% higher on a deal to buy Manus, a popular Singapore-based artificial intelligence agent with Chinese roots, in its effort to build a business around its massive AI investment. The deal values Manus at more than $2 billion, according to people familiar with the matter. It marks a rare US acquisition of an Asian tech company. - Ultragenyx (RARE) shares soared 15% today. Jefferies analysts said the stock could rebound in 2026, after the shares hit a record low Monday. - OceanFirst Financial Corp (OCFC) finished 6.6% lower, as the bank agreed to buy Flushing Financial in an all-stock deal that includes an investment agreement with PE firm Warburg Pincus, which will be represented on the company’s board.See omnystudio.com/listener for privacy information.

Warner Bros. Discovery (WBD) plans to reject a takeover bid from Paramount Skydance Corp. after the company amended the terms of its offer. The Warner Bros. board is concerned that Paramount has yet to increase its offer, which was earlier rejected as inferior to one from Netflix Inc. Molina Healthcare (MOH) rises after money manager Michael Burry highlighted the health insurer’s record of strong expense ratios and underwriting results, while praising its acquisition strategy on Substack. Ultragenyx (RARE) climb the most intraday since August 2024, rebounding after the shares hit a record low Monday on study failure. Jefferies analysts say the stock could rebound in 2026 ahead of a late-stage data update. See omnystudio.com/listener for privacy information.

On this episode of stock movers: Molina Healthcare (MOH) rises after money manager Michael Burry highlighted the health insurer’s record of strong expense ratios and underwriting results, while praising its acquisition strategy on Substack. Ultragenyx (RARE) climb the most intraday since August 2024, rebounding after the shares hit a record low Monday on study failure. Jefferies analysts say the stock could rebound in 2026 ahead of a late-stage data update. OceanFirst (OCFC) down as the bank agreed to buy Flushing Financial in an all-stock deal that includes an investment agreement with PE firm Warburg Pincus, which will be represented on the company’s board. See omnystudio.com/listener for privacy information.